Articles On Polynovo (ASX:PNV)

There are a couple of ASX 200 biotech shares that could be in the buy zone right now. The S&P/ASX 200 Index (ASX: XJO) is down -10.25% this year but many Aussie healthcare companies have surged in value. This is partly due to the natur...

Healthcare is not the favourite child it was at the start of the COVID-19 pandemic, but one index measuring the sector is still up on the wider market. Biotech Daily’s top 40 index is up 14 per cent over the last month, compared to 4 per ce...

The PolyNovo Ltd (ASX: PNV) share price has been one of the best performers on the S&P/ASX 200 Index (ASX: XJO) over the last 12 months. Since this time last year the medical device company’s shares have climbed a massive 120%. If we g...

On Wednesday the S&P/ASX 200 Index (ASX: XJO) fought hard but fell just short at the close. The benchmark index dropped 5 points to 5,775 points. Will the market be able to bounce back from this on Thursday? Here are five things to wat...

Around 12 months ago, we noted that Avita Medical (AVH) – which provides a novel approach to skin regeneration – was a business worth keeping tabs on.  Although its share price has felt the effects of the COVID-19 market sell-off, our posit...

Building a massive portfolio of ASX shares from scratch is no easy feat. Creating real wealth through the share market takes time, dedication and discipline. But it can be done, nonetheless. One thing I’ve learned over time is that sometim...

Many ASX growth shares have rocketed higher despite the bear market in 2020. The S&P/ASX 200 Index (ASX: XJO) has slumped 16.60% lower this year while many top tech and healthcare shares have surged. But with all the craziness in the s...

We’re almost 2 months on from the fastest bear market on record, which saw the S&P/ASX 200 Index (ASX: XJO) fall 36.53% from 7,162.50 points on 20 February to a low of just 4,546 on 23 March. In the time since, however, the market has...

When it comes to investing in the ASX, I always prefer to look well into the future. Markets like the S&P/ASX 200 Index (ASX: XJO) already operate based on many forward-looking mechanisms. But in order to outperform the market over the...

Polynovo Ltd (ASX: PNV) shares could be about to surge in 2020. The ASX 200 healthcare company boasts a market capitalisation of $1.71 billion at the moment, but I think it could grow to be the next CSL Limited (ASX: CSL). Why the Polynovo...

The last year has been tough. We’ve had bushfires, floods, and now coronavirus. At the time of writing, the S&P/ASX 200 Index (ASX: XJO) is down 14% from this time a year ago. But where there is disaster, there is also opportunity. We...

Due to the market crash this year, the S&P/ASX 200 Index (ASX: XJO) has recorded a 7.5% decline over the last three years. While this is disappointing, not all shares on the market are down over the period. In fact, some have generated...

Would you have invested in Amazon in the 90s, when it was a scrappy startup exploiting this new thing called the ‘world wide web’? Or would you invest once it had bedded down the book business and was getting into groceries? With hindsight...

ShareCafeOvernight: Wing And A Prayer World Overnight SPI Overnight (Jun) 5405.00 – 11.00 – 0.20% S&P ASX 200 5407.10 + 87.30 1.64% S&P500 2868.44 + 25.70 0.90% Nasdaq Comp 8809.12 + 98.41 1.13% DJIA 23883.09 + 133.33 0....

World Overnight SPI Overnight (Jun) 5405.00 – 11.00 – 0.20% S&P ASX 200 5407.10 + 87.30 1.64% S&P500 2868.44 + 25.70 0.90% Nasdaq Comp 8809.12 + 98.41 1.13% DJIA 23883.09 + 133.33 0.56% S&P500 VIX 33.61 – 2.36 – 6....

After an initial fall in line with the COVID-19 influence on the ASX 200 [XJO], the PolyNovo Ltd [ASX:PNV] share price shot up 66.27% from its low to close at $2.12, at the time of writing. PolyNovo is an Australian-based medical device com...

PolyNovo (ASX:PNV) has released the summary of results for the CP-002 Feasibility Study to assess the safety and effectiveness of NovoSorb Biodegradable Temporizing Matrix (BTM) in the treatment of severe skin burn injuries.

2020 was looking good for many companies but COVID-19 changed all that. Some have needed capital to keep going and one was sleep apnoea mouthguard maker Somnomed (ASX:SOM). In February, the company reported solid revenue and operating profi...

There is no doubt coronavirus has hit the ASX hard – the S&P/ASX 200 Index (ASX: XJO) is down 21% since the start of the year and 26% from its February high. Volatility has continued as the market has clawed its way back from its low...

Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week. Three broker buy ratings that have caught my eye are summarised below. Here’s why br...

World Overnight SPI Overnight (Jun) 5190.00 – 52.00 – 0.99% S&P ASX 200 5252.30 – 34.50 – 0.65% S&P500 2659.41 – 4.27 – 0.16% Nasdaq Comp 7887.26 – 25.98 – 0.33% DJIA 22653.86 – 26.13 – 0.12% S&P500 VIX 46.70 + 1.4...

The S&P/ASX 200 Index (ASX: XJO) was volatile again on Tuesday. Initially the ASX 200 went up as much as 2.5%. Then during the day it dropped by around 4.2% by mid-afternoon, to finish down by 0.6% compared to yesterday. Investor confi...

07 Apr 2020 - PolyNovo (ASX:PNV) report sales for the March 2020 quarter were 166 per cent greater than the March 2019 quarter ($1.69 million v. $4.49 million).

Australian medical device company PolyNovo (ASX: PNV) has posted record US sales for the March 2020 quarter, validating an earlier claim that the coronavirus pandemic would not have any material impact on its business. The company’s sales f...

The S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is pushing higher on Tuesday. In late morning trade the benchmark index is up 8% to 5,333.4 points. Four shares that are climbing more than most today are liste...

In proof that biotechs will deliver market returns even during a pandemic, two companies this morning have issued clinical trial results and watched their share prices rocket. Pot stock Zelira Therapeutics (ASX:ZLD) has received the full re...

The S&P/ASX 200 Index (ASX: XJO) has followed the lead of U.S. markets and is storming higher on Tuesday. The benchmark index is currently up 2.5% to 5,419.9 points. Three healthcare shares that are vastly outperforming the benchmark i...

ASX shares are trading at deep discounts from previous highs thanks to the coronavirus pandemic. This gives investors the chance to swoop in on some bargains. So, let’s take a look at 5 ASX shares to buy across the technology and healthca...

Director buys can be a sign that those with the most insight into a company view its shares as undervalued. Here we take a look at 4 ASX healthcare shares with multiple recent director buys.  What is insider buying? Insider buying is the p...

Despite the S&P/ASX 200 Index (ASX: XJO) plummeting lower in 2020, shares in ASX 200 healthcare group Polynovo Ltd (ASX: PNV) are still up 102% in the last 12 months. That’s good news for existing shareholders, but is there still time...

The Ramsay Health Care Limited (ASX: RHC) share price is back on form on Thursday. On Wednesday Ramsay’s shares fell heavily after the government announced that it would soon stop elective surgeries. But in afternoon trade the private hosp...

With the ASX suffering heavy falls over the past weeks, I think it’s beneficial to look back over the past year at some of our higher performing shares to remind ourselves that smart investing is very much a long-term pursuit. So, here we...

The ASX healthcare sector continues to be one of the top performers on the ASX in terms of share price rises. While most Australians are likely familiar with Cochlear Limited (ASX: COH), CSL Limited (ASX: CSL), and Ramsay Health Care Limit...

Now may not be the time to tell investors you’re about to start selling cosmetics to China, but ASX disclosure rules mean Roolife (ASX:RLG) has to unleash their news about a $1.3m revenue contract on the market today. The company has done a...

The PolyNovo Ltd (ASX: PNV) share price has burst higher during morning trade. At the time of writing the dermal regeneration focused medical device company’s shares are up 6% to $2.19. Why is the PolyNovo share price shooting higher? Inve...

Director or insider buys can be a sign that those with the most insight into a company view its shares as undervalued.  Insider buying is the purchase of shares in a company by an officer or executive of that company, such as a director. I...

Pharmaceutical company Race Oncology (ASX: RAC) has come out of a trading halt this morning to announce $1.8 million new equity funding via a strategic placement of 6 million shares. The $0.30 per share issue price represents a 9% discount...

Insider buying is the purchase of shares in a company by an officer or executive of that company, such as a director. Insiders usually have exclusive insights into the companies they manage and are likely to purchase shares when they view...

World Overnight SPI Overnight (Mar) 6413.00 + 69.00 1.09% S&P ASX 200 6391.50 – 49.70 – 0.77% S&P500 3090.23 + 136.01 4.60% Nasdaq Comp 8952.17 + 384.80 4.49% DJIA 26703.32 + 1293.96 5.09% S&P500 VIX 33.42 – 6.69 –...

After another poor start to the week for the S&P/ASX 200 (INDEXASX: XJO), a number of shares rebounded strongly yesterday afternoon. Leading the pack was logistics company WiseTech Global Ltd (ASX:WTC), which closed the day up almost 1...

World Overnight SPI Overnight (Mar) 6627.00 – 28.00 – 0.42% S&P ASX 200 6708.10 – 158.50 – 2.31% S&P500 3116.39 – 11.82 – 0.38% Nasdaq Comp 8980.77 + 15.16 0.17% DJIA 26957.59 – 123.77 – 0.46% S&P500 VIX 27.56 – 0....

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Wednesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 2.31% t...

The S&P/ASX 200 index is on course to record its third day of heavy declines in a row. In afternoon trade the benchmark index is down 2.1% to 6,721.9 points. Four shares that have fallen more than most today are listed below. Here’s wh...

At lunch on Wednesday the S&P/ASX 200 index is on course to record its third heavy decline in a row after coronavirus concerns escalated. The benchmark index is down 2.2% to 6,714.5 points. Here’s what has been happening on the market...

The high-flying PolyNovo Ltd (ASX: PNV) share price has come under pressure following the release of its half year results. At the time of writing the medical device company’s shares are down 10% to $2.71. Despite this, they are still up w...

26 Feb 2020 - PolyNovo (ASX:PNV) reports a net loss for the half year of $2.42 million, that’s 26 per cent increase from last year.

Bone healing biotech company Osteopore (ASX: OSX) has posted strong revenue growth since its ASX debut, eyeing China and the US as the next markets for its regenerative technology. The Australian and Singapore-based business listed on the...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Tuesday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 1.60% to ...

The medical technology sector is a fast-growing sector both domestically on the ASX and internationally. Here are 3 ASX med-tech shares that have seen gains of around 5% so far today. Polynovo Ltd (ASX: PNV) PolyNovo develops innovative...

The Polynovo Ltd  (ASX: PNV) share price has hit a new record high of $3.00 per share after a bumper start to the year. Why the Polynovo share price is climbing higher PolyNovo develops innovative medical devices including its patented bio...